{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:10:43Z","timestamp":1780467043533,"version":"3.54.1"},"reference-count":39,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T00:00:00Z","timestamp":1602201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000031","name":"Institute of Human Development, Child and Youth Health","doi-asserted-by":"publisher","award":["CTP 87518"],"award-info":[{"award-number":["CTP 87518"]}],"id":[{"id":"10.13039\/501100000031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To evaluate the changes in the associations of antenatal corticosteroids (ACS) with neonatal mortality and severe neurological injury over time (2003\u201317).<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>National, population\u2010representative, retrospective cohort study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Level III neonatal intensive care units participating in the Canadian Neonatal Network.<\/jats:p><\/jats:sec><jats:sec><jats:title>Population<\/jats:title><jats:p>All infants born at 23<jats:sup>0\/7<\/jats:sup>\u201333<jats:sup>6\/7<\/jats:sup> weeks of gestation (<jats:italic>n<\/jats:italic>\u00a0=\u00a043\u00a0456).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We estimated the associations between exposure to ACS and neonatal outcomes by year of birth. Year of birth was considered both continuously and categorically as three consecutive epochs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measure<\/jats:title><jats:p>Neonatal mortality and severe neurological injury.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The absolute rates of neonatal mortality and severe neurological injury decreased during the study period in both the ACS and No ACS groups. For infants born at 23<jats:sup>0\/7<\/jats:sup>\u201330<jats:sup>6\/7<\/jats:sup> weeks of gestation, ACS was associated with similar reductions in neonatal mortality across the three epochs (9.0% versus 18.1%, adjusted relative risk [aRR] 0.54, 95% CI 0.47\u20130.61 in 2003\u201309; 7.6% versus 19.6%, aRR 0.51, 95% CI 0.44\u20130.59 in 2010\u201313; and 7.3% versus 14.5%, aRR 0.56, 95% CI 0.46\u20130.68 in 2014\u201317) and in severe neurological injury (13.2% versus 25.8%, aRR 0.57, 95% CI 0.50\u20130.64 in 2003\u201309; 7.4% versus 17.4%, aRR 0.53, 95% CI 0.43\u20130.66 in 2010\u201314; and 7.2% versus 14.8%, aRR 0.59, 95% CI 0.48\u20130.74 in 2014\u201317).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Despite the ongoing improvements in neonatal care of preterm infants, as reflected by the gradual decrease in the absolute rates of neonatal mortality and severe neurological injury, the association of ACS treatment with neonatal mortality and severe neurological injury among extremely preterm infants born at 23\u201330\u00a0weeks of gestation has remained stable throughout the study period of 15\u00a0years.<\/jats:p><\/jats:sec><jats:sec><jats:title>Tweetable abstract<\/jats:title><jats:p>Despite the gradual decrease in the rates of neonatal mortality and severe neurological injury, antenatal corticosteroids remain an important intervention in the current era of neonatal care.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1471-0528.16511","type":"journal-article","created":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T23:14:19Z","timestamp":1600298059000},"page":"521-531","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Benefit of antenatal corticosteroids by year of birth among preterm infants in Canada during 2003\u20132017: a population\u2010based cohort study"],"prefix":"10.1111","volume":"128","author":[{"given":"N","family":"Melamed","sequence":"first","affiliation":[{"name":"Division of Maternal\u2010Fetal Medicine Department of Obstetrics and Gynaecology Sunnybrook Health Sciences Centre Toronto ON Canada"},{"name":"Department of Obstetrics and Gynaecology University of Toronto Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Murphy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynaecology University of Toronto Toronto ON Canada"},{"name":"Division of Maternal\u2010Fetal Medicine Department of Obstetrics and Gynaecology Mount Sinai Hospital Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Barrett","sequence":"additional","affiliation":[{"name":"Division of Maternal\u2010Fetal Medicine Department of Obstetrics and Gynaecology Sunnybrook Health Sciences Centre Toronto ON Canada"},{"name":"Department of Obstetrics and Gynaecology University of Toronto Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9468-2860","authenticated-orcid":false,"given":"E","family":"Asztalos","sequence":"additional","affiliation":[{"name":"Department of Newborn &amp; Developmental Paediatrics Sunnybrook Health Sciences Centre Toronto ON Canada"},{"name":"Department of Paediatrics University of Toronto Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4461-2178","authenticated-orcid":false,"given":"SD","family":"McDonald","sequence":"additional","affiliation":[{"name":"Division of Maternal\u2010Fetal Medicine Departments of Obstetrics and Gynaecology, Radiology, and Clinical Epidemiology and Biostatistics McMaster University Hamilton ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EW","family":"Yoon","sequence":"additional","affiliation":[{"name":"Maternal\u2010infant Care (MiCare) Research Centre Mount Sinai Hospital Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PS","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Paediatrics University of Toronto Toronto ON Canada"},{"name":"Maternal\u2010infant Care (MiCare) Research Centre Mount Sinai Hospital Toronto ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Canadian Neonatal Network (CNN), Canadian Preterm Birth Network (CPTBN) Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,10,9]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1990.tb01711.x"},{"key":"e_1_2_6_3_1","first-page":"1","article-title":"Effect of corticosteroids for fetal maturation on perinatal outcomes","volume":"12","year":"1994","journal-title":"NIH Consens Statement"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90222-8"},{"issue":"3","key":"e_1_2_6_5_1","first-page":"CD004454","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","author":"Roberts D","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.50.4.515"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.2021"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2013-0501"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2012-0547"},{"key":"e_1_2_6_10_1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1542\/peds.2010-1449","article-title":"Nosocomial infection reduction in VLBW infants with a statewide quality\u2010improvement model","volume":"127","author":"Wirtschafter DD","year":"2011","journal-title":"Pediatrics"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2016.4396"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10244"},{"key":"e_1_2_6_13_1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1542\/peds.2014-4075","article-title":"Trends in morbidity and mortality of extremely preterm multiple gestation newborns","volume":"136","author":"Yeo KT","year":"2015","journal-title":"Pediatrics"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1605566"},{"issue":"3","key":"e_1_2_6_15_1","first-page":"CD004454","article-title":"Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth","author":"Roberts D","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.04.007"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.03.009"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2016.06.012"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1970"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2393-14-272"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38547.416493.06"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jogc.2016.05.011","article-title":"We should proceed with caution when it comes to antenatal corticosteroids after 34 weeks","volume":"39","author":"Nowik CM","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2014.9"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/1471-0528.13968","article-title":"Antenatal corticosteroids are currently used excessively and more stringent controls on their use should be established: FOR: The use of antenatal corticosteroids should be restricted if we are to avoid causing harm","volume":"123","author":"Asztalos EV","year":"2016","journal-title":"BJOG"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-031197"},{"key":"e_1_2_6_26_1","unstructured":"BETAmethasone dose reduction: non\u2010inferiority on the neurocognitive outcomes of children born before 32 weeks of gestation (BETANINO).2020[https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04021485]. Accessed 16 September 2020."},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1039"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.3235"},{"key":"e_1_2_6_29_1","doi-asserted-by":"crossref","first-page":"130.e1","DOI":"10.1016\/j.ajog.2017.11.554","article-title":"Mortality and pulmonary outcomes of extremely preterm infants exposed to antenatal corticosteroids","volume":"218","author":"Travers CP","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1752"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2009.170340"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.12.039"},{"key":"e_1_2_6_33_1","first-page":"225","article-title":"Association between congenital anomalies and area\u2010level deprivation among infants in neonatal intensive care units","volume":"30","author":"Bassil KL","year":"2013","journal-title":"Am J Perinatol"},{"key":"e_1_2_6_34_1","unstructured":"Canadian Neonatal Network.Abstractor's manual.Toronto ON:Canadian Neonatal Network;2010[www.canadianneonatalnetwork.org\/portal\/]. Accessed 3 April 2014."},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1603325"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000840"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2018.04.018"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1701-2163(16)31081-7"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(78)80282-0"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516783"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1471-0528.16511","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1471-0528.16511","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1471-0528.16511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T06:17:44Z","timestamp":1693203464000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/1471-0528.16511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1111\/1471-0528.16511"],"URL":"https:\/\/doi.org\/10.1111\/1471-0528.16511","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,9]]},"assertion":[{"value":"2020-09-10","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-10-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}